Evidence map›Paper›PMID 41836949›Full record

ArticleFrontiers in medicine2026

Exploration of factors associated with turnaround time when evaluating non-tuberculous mycobacterium cultures.

Xingxing Lou, Sheng Zhao, Sipei Wang, Shanshan Jin, Tinghua Ye, Xinling Pan

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xingxing LouDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Sheng ZhaoDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Sipei WangDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Shanshan JinDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Tinghua YeDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Xinling PanDepartment of Biomedical Sciences Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A positive culture of non-tuberculous mycobacteria (NTM) is a key diagnostic criterion for NTM disease. Due to the slow growth rate of NTM, the turnaround time (TAT) for culture specimens is often lengthy, posing significant challenges for the diagnosis and treatment of related diseases. This study aimed to explore factors influencing TAT in NTM culture testing, assess its potential clinical value, and identify ways to expedite clinical decision-making. Methods: NTM identified by Results: A total of 289 NTM strains were finally enrolled in this study, including rapidly growing mycobacteria (RGM, Conclusion: TAT for NTM culture was significantly influenced by species category, with RGM showing shorter TATs than SGM. Variations in TAT were observed among different species within the same complex. Additionally, TAT was associated with clinical diagnoses and imaging findings. The acid-fast bacilli smear result was the only independent factor affecting TAT, which could help to guide clinical workflow optimization.

Indexed as

acid-fast bacilliclinical laboratoryculturenon-tuberculous mycobacteriarapidly growing mycobacteriaslow-growing mycobacteriaturnaround time

Identifiers

PMID41836949
PMCPMC12979225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.